Follow the 에스디바이오센서 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has recorded 73 reports. Market capitalisation: €855.3bn. The latest transaction was filed on 24 March 2026 (Purchase). Among the most active insiders: 김석규. The full history is openly available.
73
Insider Decl.
0
Thresholds
€2m
55 ops.
Buy Volume
·
8 ops.
Sell Volume
32Σ signal
Buys €2m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,291 of 26,220 companies
38.5
score / 100
Value
50
Quality
27
FCF yld39%
Earn yld-66%
EV/EBITDA·
ROE-18%
Gross mgn46%
Net mgn-72%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
